Table 2 Clinical characteristics and their association with CAT use
Variable | Overall N = 86 (%) | CAT users N = 58 (%) | Non-CAT users N = 28 (%) | P-value |
|---|---|---|---|---|
Diagnosis | 0.712 a | |||
Corneal disease | 14 (16.3) | 9 (15.5) | 5 (17.9) | |
Lens disease | 30 (34.9) | 22 (37.9) | 8 (28.6) | |
Retinal disease | 31 (36.0) | 21 (36.2) | 10 (35.7) | |
Others | 11 (12.8) | 6 (10.3) | 5 (17.9) | |
Symmetry of eye disease | 0.006a | |||
Unilateral | 40 (46.5) | 21 (36.2) | 19 (67.9) | |
Bilateral | 46 (53.5) | 37 (63.8) | 9 (32.1) | |
Chronicity of disease | 0.135 a | |||
Acute | 22 (25.6) | 12 (20.7) | 10 (35.7) | |
Chronic | 64 (74.4) | 46 (79.3) | 18 (64.3) | |
Route of treatment | ||||
Topical | 67 (77.9) | 43 (74.1) | 24 (85.7) | 0.277 b |
Systemic | 9 (10.5) | 7 (12.1) | 2 (7.1) | 0.712 b |
Intra-ocular injections | 18 (20.9) | 15 (25.9) | 3 (10.7) | 0.157 b |
Surgical | 48 (55.8) | 28 (48.3) | 20 (71.4) | 0.043 a |
Ocular co-morbidities | 0.695 a | |||
Absent | 59 (68.6) | 39 (67.2) | 20 (71.4) | |
Present | 27 (31.4) | 19 (32.8) | 8 (28.6) |